COMMUNIQUÉS West-GlobeNewswire
-
Higher Purpose Healing Celebrates 110+ 5-Star Google Reviews, Reinforcing Its Role as New Orleans’ Leading Trauma-Informed Healing Center
19/11/2025 -
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
19/11/2025 -
Novartis announces plans to build flagship manufacturing hub in North Carolina
19/11/2025 -
Novartis announces plans to build flagship manufacturing hub in North Carolina
19/11/2025 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 46 - 2025
19/11/2025 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 46 - 2025
19/11/2025 -
Aeroflow Health Named to The Healthcare Technology Report's Top 50 Healthcare Technology Companies of 2025
19/11/2025 -
SimpleTherapy Recognized as a Top 50 Healthcare Technology Company of 2025
19/11/2025 -
Humber River Health 10th Anniversary Event Raises Over $2.55 Million to Power the Next Decade of Innovation and Patient-Centered Care
19/11/2025 -
Curaechoice Announces Nationwide Expansion of $0-Cost Vision Care Program
19/11/2025 -
Dr. Charles Ruotolo Advances Patient-Focused Orthopedic and Sports Medicine Services
19/11/2025 -
Scientific Industries to Host Third Quarter Fiscal Year 2025 Financial Results Investor Call on November 20, 2025
19/11/2025 -
Johns Hopkins Health Plans Announces New VP of Medicare Advantage
19/11/2025 -
Spryte Medical Receives FDA IDE Approval to Initiate “INSYTE” US Pivotal Trial evaluating the nOCT Imaging System during Brain Aneurysm Treatment
19/11/2025 -
HealthEx appoints Jeremy Schwarz as Chief Commercial Officer
19/11/2025 -
Cellution Biologics Inc. Announces U.S. Launch of AmnioPlast 1 and AmnioPlast Double for Ocular Surface Repair
19/11/2025 -
USOSM Partner Practices Accredited by AAAHC, Recognized as Oral and Maxillofacial Centers of Excellence
19/11/2025 -
RespireRx Pharmaceuticals Inc. Announces NIH/NINDS Grant Award and Amended and Restated Patent License Agreement
19/11/2025 -
Longeveron Laromestrocel Data in Alzheimer’s Disease Selected for Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD 2025)
19/11/2025
Pages